AI model aims to personalize esophageal cancer care

NCT ID NCT07354295

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether an artificial intelligence (AI) system can predict how well esophageal cancer will respond to treatment and estimate a patient's long-term outlook. Researchers will collect medical images, genetic data, and other health information from 1,500 participants to train the AI model. The goal is to help doctors choose the best therapy for each person, but this study does not test a new treatment itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal cancer Esophageal Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tongji hospital, Tongji medical college, Huazhong university of science and technology

    RECRUITING

    Wuhan, Other (Non U.s.), 430030, China

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••